PATENT CLAIM ANALYSIS

Application Number: 16022578
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["544", "131000"]

Abstract:
Provided herein are deuterated compounds and compositions useful in increasing PPARδ activity. The compounds have a formula where L 5  comprises at least one deuterium. Exemplary species include The compounds and compositions provided herein are useful for the treatment of PPARδ related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).

Claim (Index 17):
The method according to  claim 8  wherein the disease is a neuronal activation disorder selected from amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Guillain-Barre syndrome, Lambert-Eaton syndrome, multiple sclerosis, myasthenia gravis, nerve lesion, peripheral neuropathy, spinal muscular atrophy, tardy ulnar nerve palsy, or toxic myoneural disorder; a muscle fatigue disorder, such as chronic fatigue syndrome, diabetes type I or II, glycogen storage disease, fibromyalgia, Friedreich's ataxia, intermittent claudication, lipid storage myopathy, MELAS, mucopolysaccharidosis, Pompe disease, or thyrotoxic myopathy.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 94.0
- Lexical Diversity: 1.40909
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15482385', '15897796', '14874008', '15517893', '15766455']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8439978769677174
- 35 USC 102 Novelty (BERT): 0.6029835665385892
- Combined Prediction Score: 0.8198964459248047
- Mean Citation Score: 574.296458
- Max Citation Score: 707.3705
- Similarity Product: 434.57000358134513

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test